Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Oligonucleotide Therapy Industry?

In recent times, there has been significant growth in the size of the oligonucleotide therapy market. The market is anticipated to expand from $5.61 billion in 2024 to $6.2 billion in 2025, signifying a compound annual growth rate (CAGR) of 10.5%. The upswing during the historical period can be linked to factors such as increased investment in research and development, the introduction of early-stage therapies, the emergence of gene editing methodologies, precocious therapeutic findings, and the launch of antisense and rnai oligonucleotides.

Expectations are high for the oligonucleotide therapy market size to experience substantial growth in the upcoming years. It is projected to escalate to “$9.66 billion by 2029, with a compound annual growth rate (CAGR) of 11.8%. The expected increase during the forecast period can be linked to various factors such as investments in research and development, global market penetration, therapeutic area expansion, disease modification strategies, and regulatory adaptations. Key trends for the forecast period encompass personalized therapies, enhancements in delivery systems, advances in RNA interference (RNAI), innovation in antisense oligonucleotide, and the incorporation of gene editing techniques.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

What Forces Are Driving The Growth Of The Oligonucleotide Therapy Industry?

The global increase in cancer incidences is predicted to enhance the growth of the oligonucleotide therapy market throughout the forecasted term. To illustrate, the American Cancer Society asserted in January 2022 that about 1.9 million new cancer cases and an estimated 609,360 cancer-related mortalities, roughly 1,670 daily, are projected in the US. The four cancers most commonly diagnosed worldwide are lung, prostate, bowel, and female breast cancer, which constitute 43 percent of all new cancer diagnoses. Given this, the global surge in cancer incidence rates is expected to generate increased demand for the oligonucleotide therapy market in upcoming years.

The oligonucleotide therapy market covered in this report is segmented –

1) By Type: Antisense Oligonucleotide, Aptamer, Other Types

2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User

3) By End User: Hospitals, Research Institutes

Subsegments:

1) By Antisense Oligonucleotide: RNA-Targeted Antisense Oligonucleotides, DNA-Targeted Antisense Oligonucleotides, Chemically Modified Antisense Oligonucleotides

2) By Aptamer: DNA Aptamers, RNA Aptamers, Small Molecule Aptamers

3) By Other Types: siRNA (Small Interfering RNA), miRNA (Micro RNA), DNAzyme And Ribozymes, Synthetic Oligonucleotides For Gene Editing

What Long-Term Trends Are Likely To Affect The Oligonucleotide Therapy Market?

Providers and developers in the oligonucleotide therapy market are putting significant efforts into research and development to refine the therapy design to mitigate impacts on patients. The latest oligonucleotides being created facilitate precision medicine techniques and can be specifically crafted to target any gene with the least side effects. It also aids in pinpointing patient-specific sequences leading to rare ailments. In the month of April in 2023, the FDA gave approval to Qalsody, a type of antisense oligonucleotide (ASO), to be used for treating amyotrophic lateral sclerosis (ALS) patients with a mutation in the superoxide dismutase 1 (SOD1) gene. The function of Qalsody is to target SOD1 mRNA, thereby decreasing the production of SOD1 protein.

Who Are The Primary Players Operating Across The Global Oligonucleotide Therapy Market?

Major companies operating in the oligonucleotide therapy market include Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Gilead Sciences Inc., BioNTech SE, Moderna Inc., Biogen Inc., Jazz Pharmaceuticals plc, QIAGEN Company, Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Ionis Pharmaceuticals Inc., Akcea Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., SomaGenics Inc., Wave Life Sciences Ltd., Exicure Inc., Avidity Biosciences Inc., Miragen Therapeutics Inc., ProQR Therapeutics NV, Regulus Therapeutics Inc., Kastle Therapeutics LLC, Santaris Pharma A/S, InteRNA Technologies B.V., Dynacure S.A., Arcturus Therapeutics Holdings Inc., Intellia Therapeutics Inc., Regeneron Pharmaceuticals Inc., Editas Medicine Inc., Evox Therapeutics Ltd., PepGen Ltd.

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Which Region Offers The Most Growth Potential For The Oligonucleotide Therapy Market Through 2029?

North America was the largest region in the oligonucleotide therapy market in 2024. The regions covered in the oligonucleotide therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3398&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model